global glp-1 obesity drug market size forecast 2030 GLP-1 Market Size, Scope, Forecast
Description
Standards of medical care in diabetes2022
196,197,198 The phosphorylation of Akt is necessary for its full activation, allowing it to regulate a variety of downstream effector proteins involved in cell survival, proliferation, metabolism, and glucose transport
Among those who have been diagnosed with diabetes, 14.1% report using these drugs for weight loss purposes, slightly higher than the general adult population
To address this, the American Journal of Clinical Nutrition released dietary guidelines for GLP-1 users in July 2025
The GLP-1 receptor is expressed in the gut, pancreas, brainstem, hypothalamus and vagal afferent nerves [35]
